Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME

30 August 2016 (14:54 - 15:12)
Organised by:
Congress Presentation Part of: A perspective on the effects of Empaglifozin in cardiovascular outcomes Drug therapy ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by